Mastrangelo D - Search Results

1

High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro.

Noguera NI, Pelosi E, Angelini DF, Piredda ML, Guerrera G, Piras E, Battistini L, Massai L, Berardi A, Catalano G, Cicconi L, Castelli G, D'Angiò A, Pasquini L, Graziani G, Fioritoni G, Voso MT, Mastrangelo D, Testa U, Lo-Coco F. Noguera NI, et al. Among authors: mastrangelo d. Oncotarget. 2017 May 16;8(20):32550-32565. doi: 10.18632/oncotarget.15925. Oncotarget. 2017. PMID: 28427227 Free PMC article.

2

Cytotoxic effects of high concentrations of sodium ascorbate on human myeloid cell lines.

Mastrangelo D, Massai L, Lo Coco F, Noguera NI, Borgia L, Fioritoni G, Berardi A, Iacone A, Muscettola M, Pelosi E, Castelli G, Testa U, Di Pisa F, Grasso G. Mastrangelo D, et al. Ann Hematol. 2015 Nov;94(11):1807-16. doi: 10.1007/s00277-015-2464-2. Epub 2015 Aug 12. Ann Hematol. 2015. PMID: 26264692

3

Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulation.

Mastrangelo D, Pelosi E, Castelli G, Lo-Coco F, Testa U. Mastrangelo D, et al. Blood Cells Mol Dis. 2018 Mar;69:57-64. doi: 10.1016/j.bcmd.2017.09.005. Epub 2017 Sep 21. Blood Cells Mol Dis. 2018. PMID: 28954710 Review.

4

Italian register for retinoblastoma. Pros and cons of a retrospective statistical study.

Mastrangelo D, Acquaviva A, Di Pisa F, Hadjistilianou T, Frezzotti R. Mastrangelo D, et al. Ophthalmic Paediatr Genet. 1991 Jun;12(2):73-8. doi: 10.3109/13816819109023677. Ophthalmic Paediatr Genet. 1991. PMID: 1923316

5

Retinoblastoma. Analysis of 75 cases and proposal for a new model of oncogenesis and tumor growth kinetics.

Mastrangelo D, Di Pisa F, Hadjistilianou T, Bardelli AM, Silvestri S, Frezzotti R. Mastrangelo D, et al. Ophthalmic Paediatr Genet. 1989 Sep;10(3):161-71. doi: 10.3109/13816818909009872. Ophthalmic Paediatr Genet. 1989. PMID: 2587028

6

Design and implementation of a relational database used in the management of patients with retinoblastoma.

Di Pisa F, Mastrangelo D, Hadjistilianou T, Squitieri N, Rinaldo F, Donoso L, Frezzotti R. Di Pisa F, et al. Among authors: mastrangelo d. Comput Biomed Res. 1997 Aug;30(4):273-89. doi: 10.1006/cbmr.1997.1447. Comput Biomed Res. 1997. PMID: 9339322

7

Metachronous tumor development in unilateral retinoblastoma.

Mastrangelo D, Hadjistilianou T, Di Pisa F, Capretti MC, Frezzotti R. Mastrangelo D, et al. Eur J Ophthalmol. 2000 Apr-Jun;10(2):149-52. doi: 10.1177/112067210001000210. Eur J Ophthalmol. 2000. PMID: 10887927

8

The retinoblastoma paradigm revisited.

Mastrangelo D, De Francesco S, Di Leonardo A, Lentini L, Hadjistilianou T. Mastrangelo D, et al. Med Sci Monit. 2008 Dec;14(12):RA231-40. Med Sci Monit. 2008. PMID: 19043380 Review.

9

The polymerase chain reaction (PCR) in the routine genetic characterization of retinoblastoma: a tool for the clinical laboratory.

Mastrangelo D, Squitieri N, Bruni S, Hadjistilianou T, Frezzotti R. Mastrangelo D, et al. Surv Ophthalmol. 1997 Jan-Feb;41(4):331-40. doi: 10.1016/s0039-6257(96)00004-5. Surv Ophthalmol. 1997. PMID: 9104770 Review.

10

Retinoblastoma epidemiology: does the evidence matter?

Mastrangelo D, De Francesco S, Di Leonardo A, Lentini L, Hadjistilianou T. Mastrangelo D, et al. Eur J Cancer. 2007 Jul;43(10):1596-603. doi: 10.1016/j.ejca.2007.04.019. Epub 2007 May 31. Eur J Cancer. 2007. PMID: 17543516 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page